[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342842-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342842-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-e2f2-in-cancer-progression-and-its-value-as-a-therapeutic-target-review","The role of E2F2 in cancer progression and its value as a therapeutic target - review","","E2F2 is a transcription factor that drives cell-cycle progression and proliferation. In malignancies, aberrant E2F2 expression or activation is frequently observed and supports tumor growth, angiogenesis, and invasiveness. E2F2 influences multiple cellular programs, including apoptosis and DNA repair, through interactions with auxiliary factors and downstream targets. Dysregulation can result from upstream regulatory changes and epigenetic alterations. The review surveys E2F2 roles in cancer progression and summarizes established and emerging therapeutic strategies targeting this oncogenic pathway, enabling further biological and clinical exploration.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-e2f2-in-cancer-progression-and-its-value-as-a-therapeutic-target-review/342842/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-e2f2-in-cancer-progression-and-its-value-as-a-therapeutic-target-review/342842.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does E2F2 regulate in cancer-related biology?","Question",{"text":63,"@type":64},"E2F2 regulates cell-cycle progression and cell proliferation. It also affects processes such as apoptosis and DNA repair, contributing to tumor-promoting phenotypes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How can E2F2 become dysregulated in carcinogenesis?",{"text":68,"@type":64},"The review indicates dysregulation of E2F2 may stem from upstream regulatory element modifications and epigenetic alterations.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is E2F2 considered a therapeutic target?",{"text":72,"@type":64},"E2F2 contributes to tumor development and progression and is linked to the efficacy of some anti-tumor drugs. Targeting this pathway may offer a basis for therapeutic strategies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342842,1791077927,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","TYPE Review  \nPUBLISHED 14 May 2024  \nDOI 10.3389/fimmu.2024.1397303  \nOPEN ACCESS  \nEDITED BY  \nArumugam Jayakumar,  \nUniversity of Texas MD Anderson Cancer Center, United States  \nREVIEWED BY  \nVidya Gopakumar,  \nCase Western Reserve University, United States  \nMatias I. Hepp,  \nUniversidad Cato´lica de la Santsima Concepcio´n, Chile  \n*CORRESPONDENCE Yang Gao  \n[yxgaoyang@163.com](yxgaoyang@163.com)[ ](yxgaoyang@163.com)Wenzhou Zhang  \n [hnzzzwzx@sina.com](hnzzzwzx@sina.com)  \nRECEIVED 07 March 2024  \nACCEPTED 30 April 2024  \nPUBLISHED 14 May 2024  \nCITATION  \nGao Y, Qiao X, Liu Z and Zhang W (2024) The role of E2F2 in cancer progression and its value as a therapeutic target.  \nFront. Immunol. 15:1397303 .  \ndoi: 10.3389/fimmu.2024.1397303  \nCOPYRIGHT  \n© 2024 Gao, Qiao, Liu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe role of E2F2 in cancer progression and its value as a therapeutic target  \nYang Gao 1*, Xinjie Qiao 2, Zhenhui Liu 1 and Wenzhou Zhang 1*  \n1 Department of Pharmacy, The Afﬁliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China, 2 Department of Rhinology, The First Afﬁliated Hospital of Zhengzhou University, Zhengzhou, China  \nThe E2F family of transcription factors plays a crucial role in the regulation of cell cycle progression and cell proliferation. Accumulative evidence indicates that aberrant expression or activation of E2F2 is a common phenomenon inmalignances. E2F2 has emerged as a key player in the development and progression of various types of tumors. A wealth of research has substantiated that E2F2 could contribute to the enhancement of tumor cell proliferation, angiogenesis, and invasiveness. Moreover, E2F2 exerts its inﬂuence on a myriad of cellular processes by engaging with a spectrum of auxiliary factors and downstream targets, including apoptosis and DNA repair. The dysregulation of E2F2 in the context of carcinogenesis may be attributable to a multitude of mechanisms, which encompass modiﬁcations in upstream regulatory elements or epigenetic alterations. This review explores the function of E2F2 in cancer progression and both established and emerging therapeutic strategies aiming at targeting this oncogenic pathway, while also providing a strong basis for further research on the biological function and clinical applications of E2F2 .  \nKEYWORDS  \nE2F2, cancer progression, therapeutic target, function, strategy  \n1 Introduction  \nThe E2F family is an important transcription factor (TF) which plays a critical regulatory role in the cell cycle. E2F family members are deﬁned by their DNA binding domain (DBD), and to date, eight members, contain E2F1-E2F8, have been identiﬁed, which encode for nine different gene products (1, 2). E2F transcription factor 2 (E2F2) is a transcription factor belonging to the E2F family. E2F2 is involved in biological processes such as cell cycle regulation, cell differentiation and apoptosis. When the cell enters the S phase, E2F2 can combine with DP1 to form a complex that promotes DNA synthesis and the normal progression of the cell cycle (3) . In addition, E2F2 is also involved in regulating the transcriptional activities of many other genes, such as BAX, p73, p16INK4a, etc. (4). E2F2 plays an important role in a variety of physiological and pathological conditions, including biochemistry, molecular biology, cell and developmental biology, and oncology and so an. In  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \ncancer, overexpression of E2F2 has been found in various types of cancer, and the abn","cbCaiggcZEwBHAds","https://ap.wps.com/l/cbCaiggcZEwBHAds","pdf",478056,"English","# Introduction\n## E2F family and functions of E2F2\n# Discovery, structure, and distribution of E2F2\n## Genomic location and molecular interactions","[{\"question\":\"What does E2F2 regulate in cancer-related biology?\",\"answer\":\"E2F2 regulates cell-cycle progression and cell proliferation. It also affects processes such as apoptosis and DNA repair, contributing to tumor-promoting phenotypes.\"},{\"question\":\"How can E2F2 become dysregulated in carcinogenesis?\",\"answer\":\"The review indicates dysregulation of E2F2 may stem from upstream regulatory element modifications and epigenetic alterations.\"},{\"question\":\"Why is E2F2 considered a therapeutic target?\",\"answer\":\"E2F2 contributes to tumor development and progression and is linked to the efficacy of some anti-tumor drugs. Targeting this pathway may offer a basis for therapeutic strategies.\"}]","The role of E2F2 in cancer progression and its value as a therapeutic target - review | PDF",1790048394,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e096686067b4c52bb673bcfd98ed5ad3.webp",983,1389,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1797c9763eac3841e6cbfba3341ba46.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a38d5e5159b012f4a9a136a25b8dfa63.webp",981,1386,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/730beb7ab57ca4f57f63f9f8e6aeaa77.webp",980,1385]